Adding a high dose of erythropoietin to therapeutic hypothermia did not reduce rates of death or disability in infants with ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study. The ...

Erythropoietin did not reduce the risk for death or severe disability among infants with hypoxic ischemic encephalopathy ...

By Karen Roman ReAlta Life Sciences said it is presenting new data from its hypoxic ischemic encephalopathy (HIE) program at ...

Newborns deprived of oxygen have their temperatures lowered to protect against brain damage, but it’s hard to decipher the babies’ immediate response to the intervention. A series of rodent ...

Pune: PMC's maternal death review report on Friday cited hypoxic encephalopathy, along with lactic acidosis and and disseminated intravascular coagulation, as the cause of Tanisha alias Ishwari ...

The Company’s lead candidate, RLS-0071 (pegtarazimod), has received FDA Orphan Drug Designation and Fast Track Designations for hypoxic ischemic encephalopathy (HIE), a devastating disease that ...

KIM-1 is a transmembrane protein that is not detectable in normal kidney tissue and expressed at very high levels in urine after ischemic and toxic injury. The aim of this study was to estimate ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not ...